United’s Passenger Debacle An Immaterial Investment Consideration
April 18, 2017
Image Source: Business Insider The major airlines in the US have done a fantastic job capitalizing on the ongoing upswing in air travel demand, but their economically-sensitive business models remain the most operationally-leveraged out of any industry group in our coverage. This should be investors’ biggest concern: A downturn in the global economy and competitive pricing pressures are far greater worries for investors than United’s recent passenger debacle. However, as with many news-oriented items (as opposed to materially-relevant, investment-related items), United’s misstep is making headlines in a big way. Though the footage in this article is appalling, investors in airline stocks have much more important things to worry about, in our view. By Brian Nelson, CFA The airline industry has
Dividend Increases/Decreases for the Week Ending April 14
April 17, 2017
Below we provide a list of firms that raised/lowered their dividends during the week ending April 14. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Antero Midstream (AM): now $0.30 per share quarterly dividend, was $0.28. Citi Trends (CTRN): now $0.08 per share quarterly dividend, was $0.06. Euronext NV (EUXTF): now EUR 1.42 per share annual dividend, was EUR 1.24. Foot Locker (FL): now $0.31 per share quarterly dividend, was $0.275. Genesis Energy (GEL): now $0.72 per share quarterly dividend, was $0.71. Gladstone Investment (GAIN): now $0.064 per share monthly dividend,
Trash As A Source of Cash and 2 New Additions to the Best Ideas Newsletter Portfolio
April 13, 2017
Image Source: thetaxhaven We’re making a number of adjustments to the Best Ideas Newsletter portfolio. By Kris Rosemann and Brian Nelson, CFA It’s time to take out the trash… that is, trash hauler Republic Services (RSG) from the Best Ideas Newsletter portfolio (it’s not “trash” – it’s actually a fantastic company and has been a great stock, but boy is it pricey now). We’re also adding ~1.5% positions in two new ideas, Dollar General (DG) and Verint Systems (VRNT), in the Best Ideas Newsletter portfolio as both have attractive valuations, in our view. Dollar General’s 27 consecutive years of same-store-sales growth are impressive, and Verint is now at the low end of its short-term uptrend, offering an interesting entry point
Three Notable Pending FDA Approvals
April 11, 2017
Image Source: Brandon Giesbrecht The final step of the drug approval process is the filing of a new drug application (NDA), when the FDA assesses trial results before deciding if the treatment warrants marketing approval. A delay or rejection can have a meaningful impact on the equity price, so let’s dig into a few notable upcoming decisions. By Alexander J. Poulos and Kris Rosemann Baricitinib Baricitinib is a Janus Kinase 1&2 inhibitor that is being studied for the treatment of a wide range of inflammatory diseases, and clinical trials for the indication of rheumatoid arthritis conclusively demonstrated superiority to placebo–and Humira. The superiority to Humira, in our view, is a key differentiator in the crowded inflammatory disease market, a direct result
Dividend Increases/Decreases for the Week Ending April 7
April 10, 2017
Below we provide a list of firms that raised/lowered their dividends during the week ending April 7. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Bank of the Ozarks (OZRK): now $0.175 per share quarterly dividend, was $0.17. BP Prudhoe Bay Royalty Trust (BPT): now $1.0983 per share quarterly dividend, was $0.9943. Carnival (CCL): now $0.40 per share quarterly dividend, was $0.35. Chico’s FAS (CHS): now $0.0825 per share quarterly dividend, was $0.08. Cisco (CSCO): now $0.29 per share quarterly dividend, was $0.26. Constellation Brands (STZ): now $0.52 per share quarterly
Panera Eaten Up; SeaDrill’s End, Cisco’s Dividend Hike and Much More
April 7, 2017
Let’s go around the horn with recent investment-related news. Let’s say goodbye to Panera, talk about SeaDrill’s infamous demise, follow up on the Coach dividend saga, address Cisco’s payout strength and attractive valuation, update readers on Medtronic’s portfolio optimization initiatives, and try to reason through Tesla’s recent price surge. By Kris Rosemann and Brian Nelson, CFA Goodbye Panera I think most of us were surprised a bit Wednesday morning, April 5, to see Panera Bread (PNRA) taken private by JAB Holding Company for $315 per share in cash. Shares of Panera started the year just above the $200 price tag, so the buyout is a nice payoff for investors that have been holding strong in the fast-casual concept. JAB
New Taxes? Trump’s Misstep and Seeming About-Face
April 4, 2017
Image Source: FactSet and Valuentum estimates (2019, 2020) News that Trump was considering new taxes, his failure to repeal Obamacare, and the seeming about-face on for-profit education regulations have put the probability of corporate tax reform in jeopardy, from where we stand. If we’re right, the implications on the market could be considerable… and not in a good way. Let’s talk about this in the context of current market valuations. By Brian Nelson, CFA The shot across the bow has been fired. The news came and went, and many seemed to ignore its potential massive implications. What am I talking about? As you have read by now, Donald Trump’s first major move as President has resulted in failure–a divided Republican
Can Vertex Pharmaceuticals Dominate the Race to Treat Cystic Fibrosis?
April 4, 2017
Tickerized for holdings in the XLV and IBB. Cystic Fibrosis is a rare disease that afflicts an estimated seventy-five thousand patients worldwide. Vertex Pharmaceuticals is the first to market with a combination treatment to treat a portion of the overall patient population. Will Vertex win the race to bring forth a triple therapy to treat the vast majority of those afflicted? By Alexander J. Poulos Cystic fibrosis (CF) is a recessive genetic disorder. The patient that is afflicted will carry two copies of the cystic fibrosis conductance regulator protein (CFTR) gene. The CFTR gene allows the body to produce the CFTR protein, whose function is to remove chloride from the cells. Patients that have CF will suffer from a “thickening”
Dividend Increases for the Week Ending March 31
April 3, 2017
Below we provide a list of firms that raised their dividends during the week ending March 31. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Activision Blizzard (ATVI): now $0.30 per share quarterly dividend, was $0.26. Amdocs (DOX): now $0.22 per share quarterly dividend, was $0.195. Ares Commercial Real Estate (ACRE): now $0.27 per share quarterly dividend, was $0.26. Banner (BANR): now $0.25 per share quarterly dividend, was $0.23. City Holding (CHCO): now $0.44 per share quarterly dividend, was $0.43. CyrusOne (CONE): now $0.42 per share quarterly dividend, was $0.38. Elbit
First Quarter 2017 Comes To A Close
April 1, 2017
“Be sure to continue to study the difference between price and value—just because a stock’s price has advanced doesn’t make it more expensive if the value of its enterprise has increased at a faster rate. If you understand this concept, you may be smarter than 99.9% of the investing population.” – Brian Nelson, CFA By Brian Nelson, CFA The first quarter of 2017 came and went. Including dividends, the S&P 500 (SPY) roared nearly 6% higher during the period thanks to solid gains from the land of technology, an area that we have liked for the longest time. The Technology Select Sector SPDR (XLK) advanced more than 10% during the period, and key technology holdings in the Dividend Growth Newsletter
